Cancer or Tumor Profiling Market Report

China Cancer or Tumor Profiling Industry Market Research Report 2023-2029

  • POSTDATE：Sep 29, 2023
  • PAGES：205
  • REPORT CODE：GMM1818610
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Cancer or Tumor Profiling industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Oxford Gene Technology

    • Caris Life Sciences Helomics Corporation

    • Personal Genome Diagnostics

    • Ribomed Biotechnologies, Inc

    • Genomic Health Inc

    • Foundation Medicine

    • Qiagen NV

    • Nanostring Technologies

    • GenomeDX

    • HTG Molecular Diagnostics

    • Guardant Health

    By Type:

    • Epigenetics

    • Metabolomics

    • Genomics

    • Proteomics

    By Application:

    • Prognostics

    • Diagnostics

    • Personalized Medicine

    • Biomarker Discovery

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Cancer or Tumor Profiling Market Overview 2018-2029

    • 1.1 China Cancer or Tumor Profiling Industry Development Overview

    • 1.2 China Cancer or Tumor Profiling Industry Development History

    • 1.3 China Cancer or Tumor Profiling Industry Market Size (2018-2029)

    • 1.4 China Cancer or Tumor Profiling Market Analysis by Type from Production Side

      • 1.4.1 China Cancer or Tumor Profiling Production Volume, Production Value and Growth Rate of Epigenetics (2018-2029)

      • 1.4.2 China Cancer or Tumor Profiling Production Volume, Production Value and Growth Rate of Metabolomics (2018-2029)

      • 1.4.3 China Cancer or Tumor Profiling Production Volume, Production Value and Growth Rate of Genomics (2018-2029)

      • 1.4.4 China Cancer or Tumor Profiling Production Volume, Production Value and Growth Rate of Proteomics (2018-2029)

    • 1.5 China Cancer or Tumor Profiling Market Analysis by Application from Consumption End

      • 1.5.1 China Cancer or Tumor Profiling Sales Volume, Sales Value and Growth Rate of Prognostics (2018-2029)

      • 1.5.2 China Cancer or Tumor Profiling Sales Volume, Sales Value and Growth Rate of Diagnostics (2018-2029)

      • 1.5.3 China Cancer or Tumor Profiling Sales Volume, Sales Value and Growth Rate of Personalized Medicine (2018-2029)

      • 1.5.4 China Cancer or Tumor Profiling Sales Volume, Sales Value and Growth Rate of Biomarker Discovery (2018-2029)

    • 1.6 China Cancer or Tumor Profiling Market Analysis by Region

      • 1.6.1 North China Cancer or Tumor Profiling Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Cancer or Tumor Profiling Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Cancer or Tumor Profiling Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Cancer or Tumor Profiling Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Cancer or Tumor Profiling Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Cancer or Tumor Profiling Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Cancer or Tumor Profiling Market Size and Growth Rate from 2018-2029

    Chapter 2 China Cancer or Tumor Profiling Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Cancer or Tumor Profiling Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Cancer or Tumor Profiling Market Status and Competition Analysis in 2023

      • 2.2.3 China Cancer or Tumor Profiling Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Cancer or Tumor Profiling Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Cancer or Tumor Profiling Industry Development

    Chapter 3 Cancer or Tumor ProfilingIndustry Chain Analysis

    • 3.1 Cancer or Tumor Profiling Industry Chain

    • 3.2 Cancer or Tumor Profiling Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Cancer or Tumor Profiling Market

    • 3.3 Cancer or Tumor Profiling Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Cancer or Tumor Profiling Market

    Chapter 4 China Cancer or Tumor Profiling Market, by Type

    • 4.1 China Cancer or Tumor Profiling Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Cancer or Tumor Profiling Total Production Volume and Growth Rate from Production Side

    • 4.5 China Cancer or Tumor Profiling Production Volume and Growth Rate, by Type

      • 4.5.1 China Cancer or Tumor Profiling Production Volume and Growth Rate of Epigenetics

      • 4.5.2 China Cancer or Tumor Profiling Production Volume and Growth Rate of Metabolomics

      • 4.5.3 China Cancer or Tumor Profiling Production Volume and Growth Rate of Genomics

      • 4.5.4 China Cancer or Tumor Profiling Production Volume and Growth Rate of Proteomics

    Chapter 5 China Cancer or Tumor Profiling Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Cancer or Tumor Profiling Total Market Size and Growth Rate from Consumption End

    • 5.5 China Cancer or Tumor Profiling Market Size and Growth Rate, by Application

      • 5.5.1 China Cancer or Tumor Profiling Market Size and Growth Rate of Prognostics

      • 5.5.2 China Cancer or Tumor Profiling Market Size and Growth Rate of Diagnostics

      • 5.5.3 China Cancer or Tumor Profiling Market Size and Growth Rate of Personalized Medicine

      • 5.5.4 China Cancer or Tumor Profiling Market Size and Growth Rate of Biomarker Discovery

    Chapter 6 China Cancer or Tumor Profiling Market, by Region

    • 6.1 China Cancer or Tumor Profiling Production Volume and Production Value, by Region

    • 6.2 China Cancer or Tumor Profiling Sales Volume and Sales Value, by Region

    Chapter 7 North China Cancer or Tumor Profiling Market Analysis

    • 7.1 North China Cancer or Tumor Profiling Market, by Type

    • 7.2 North China Cancer or Tumor Profiling Market, by Application

    Chapter 8 Central China Cancer or Tumor Profiling Market Analysis

    • 8.1 Central China Cancer or Tumor Profiling Market, by Type

    • 8.2 Central China Cancer or Tumor Profiling Market, by Application

    Chapter 9 South China Cancer or Tumor Profiling Market Analysis

    • 9.1 South China Cancer or Tumor Profiling Market, by Type

    • 9.2 South China Cancer or Tumor Profiling Market, by Application

    Chapter 10 East China Cancer or Tumor Profiling Market Analysis

    • 10.1 East China Cancer or Tumor Profiling Market, by Type

    • 10.2 East China Cancer or Tumor Profiling Market, by Application

    Chapter 11 Northeast China Cancer or Tumor Profiling Market Analysis

    • 11.1 Northeast China Cancer or Tumor Profiling Market, by Type

    • 11.2 Northeast China Cancer or Tumor Profiling Market, by Application

    Chapter 12 Southwest China Cancer or Tumor Profiling Market Analysis

    • 12.1 Southwest China Cancer or Tumor Profiling Market, by Type

    • 12.2 Southwest China Cancer or Tumor Profiling Market, by Application

    Chapter 13 Northwest China Cancer or Tumor Profiling Market Analysis

    • 13.1 Northwest China Cancer or Tumor Profiling Market, by Type

    • 13.2 Northwest China Cancer or Tumor Profiling Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Oxford Gene Technology

        • 14.1.1 Oxford Gene Technology Company Profile

        • 14.1.2 Oxford Gene Technology Cancer or Tumor Profiling Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Caris Life Sciences Helomics Corporation

        • 14.2.1 Caris Life Sciences Helomics Corporation Company Profile

        • 14.2.2 Caris Life Sciences Helomics Corporation Cancer or Tumor Profiling Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Personal Genome Diagnostics

        • 14.3.1 Personal Genome Diagnostics Company Profile

        • 14.3.2 Personal Genome Diagnostics Cancer or Tumor Profiling Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Ribomed Biotechnologies, Inc

        • 14.4.1 Ribomed Biotechnologies, Inc Company Profile

        • 14.4.2 Ribomed Biotechnologies, Inc Cancer or Tumor Profiling Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Genomic Health Inc

        • 14.5.1 Genomic Health Inc Company Profile

        • 14.5.2 Genomic Health Inc Cancer or Tumor Profiling Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Foundation Medicine

        • 14.6.1 Foundation Medicine Company Profile

        • 14.6.2 Foundation Medicine Cancer or Tumor Profiling Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Qiagen NV

        • 14.7.1 Qiagen NV Company Profile

        • 14.7.2 Qiagen NV Cancer or Tumor Profiling Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Nanostring Technologies

        • 14.8.1 Nanostring Technologies Company Profile

        • 14.8.2 Nanostring Technologies Cancer or Tumor Profiling Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 GenomeDX

        • 14.9.1 GenomeDX Company Profile

        • 14.9.2 GenomeDX Cancer or Tumor Profiling Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 HTG Molecular Diagnostics

        • 14.10.1 HTG Molecular Diagnostics Company Profile

        • 14.10.2 HTG Molecular Diagnostics Cancer or Tumor Profiling Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Guardant Health

        • 14.11.1 Guardant Health Company Profile

        • 14.11.2 Guardant Health Cancer or Tumor Profiling Market Performance

        • 14.11.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Cancer or Tumor Profiling Industry Research Conclusions

    • 15.2 Cancer or Tumor Profiling Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Cancer or Tumor Profiling Industry Market Size (2018-2029)

    • Figure China Cancer or Tumor Profiling Production Volume, Production Value and Growth Rate of Epigenetics (2018-2029)

    • Figure China Cancer or Tumor Profiling Production Volume, Production Value and Growth Rate of Metabolomics (2018-2029)

    • Figure China Cancer or Tumor Profiling Production Volume, Production Value and Growth Rate of Genomics (2018-2029)

    • Figure China Cancer or Tumor Profiling Production Volume, Production Value and Growth Rate of Proteomics (2018-2029)

    • Figure China Cancer or Tumor Profiling Sales Volume, Sales Value and Growth Rate of Prognostics (2018-2029)

    • Figure China Cancer or Tumor Profiling Sales Volume, Sales Value and Growth Rate of Diagnostics (2018-2029)

    • Figure China Cancer or Tumor Profiling Sales Volume, Sales Value and Growth Rate of Personalized Medicine (2018-2029)

    • Figure China Cancer or Tumor Profiling Sales Volume, Sales Value and Growth Rate of Biomarker Discovery (2018-2029)

    • Figure North China Cancer or Tumor Profiling Market Size and Growth Rate from 2018-2029

    • Figure Central China Cancer or Tumor Profiling Market Size and Growth Rate from 2018-2029

    • Figure South China Cancer or Tumor Profiling Market Size and Growth Rate from 2018-2029

    • Figure East China Cancer or Tumor Profiling Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Cancer or Tumor Profiling Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Cancer or Tumor Profiling Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Cancer or Tumor Profiling Market Size and Growth Rate from 2018-2029

    • Figure Cancer or Tumor Profiling Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Cancer or Tumor Profiling Market Share by Type in 2018

    • Figure China Cancer or Tumor Profiling Market Share by Type in 2023

    • Figure China Cancer or Tumor Profiling Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Cancer or Tumor Profiling Production Volume and Growth Rate of Epigenetics (2018-2023)

    • Figure China Cancer or Tumor Profiling Production Volume and Growth Rate of Metabolomics (2018-2023)

    • Figure China Cancer or Tumor Profiling Production Volume and Growth Rate of Genomics (2018-2023)

    • Figure China Cancer or Tumor Profiling Production Volume and Growth Rate of Proteomics (2018-2023)

    • Figure China Cancer or Tumor Profiling Market Share by Application in 2018

    • Figure China Cancer or Tumor Profiling Market Share by Application in 2023

    • Figure China Cancer or Tumor Profiling Total Market Size and Growth Rate from Consumption End

    • Figure China Cancer or Tumor Profiling Market Size and Growth Rate of Prognostics (2018-2023)

    • Figure China Cancer or Tumor Profiling Market Size and Growth Rate of Diagnostics (2018-2023)

    • Figure China Cancer or Tumor Profiling Market Size and Growth Rate of Personalized Medicine (2018-2023)

    • Figure China Cancer or Tumor Profiling Market Size and Growth Rate of Biomarker Discovery (2018-2023)

    • Table China Cancer or Tumor Profiling Production Volume by Region (2018-2023)

    • Table China Cancer or Tumor Profiling Production Volume Share by Region (2018-2023)

    • Figure China Cancer or Tumor Profiling Production Volume Share by Region (2018-2023)

    • Table China Cancer or Tumor Profiling Production Value by Region (2018-2023)

    • Table China Cancer or Tumor Profiling Production Value Share by Region (2018-2023)

    • Figure China Cancer or Tumor Profiling Production Value Share by Region (2018-2023)

    • Table China Cancer or Tumor Profiling Sales Volume by Region (2018-2023)

    • Table China Cancer or Tumor Profiling Sales Volume Share by Region (2018-2023)

    • Figure China Cancer or Tumor Profiling Sales Volume Share by Region (2018-2023)

    • Table China Cancer or Tumor Profiling Sales Value by Region (2018-2023)

    • Table China Cancer or Tumor Profiling Sales Value Share by Region (2018-2023)

    • Figure China Cancer or Tumor Profiling Sales Value Share by Region (2018-2023)

    • Table North China Cancer or Tumor Profiling Production Volume by Type (2018-2023)

    • Table North China Cancer or Tumor Profiling Production Volume Share by Type (2018-2023)

    • Figure North China Cancer or Tumor Profiling Production Volume Share by Type (2018-2023)

    • Table North China Cancer or Tumor Profiling Sales Volume by Application (2018-2023)

    • Table North China Cancer or Tumor Profiling Sales Volume Share by Application (2018-2023)

    • Figure North China Cancer or Tumor Profiling Sales Volume Share by Application (2018-2023)

    • Table Central China Cancer or Tumor Profiling Production Volume by Type (2018-2023)

    • Table Central China Cancer or Tumor Profiling Production Volume Share by Type (2018-2023)

    • Figure Central China Cancer or Tumor Profiling Production Volume Share by Type (2018-2023)

    • Table Central China Cancer or Tumor Profiling Sales Volume by Application (2018-2023)

    • Table Central China Cancer or Tumor Profiling Sales Volume Share by Application (2018-2023)

    • Figure Central China Cancer or Tumor Profiling Sales Volume Share by Application (2018-2023)

    • Table South China Cancer or Tumor Profiling Production Volume by Type (2018-2023)

    • Table South China Cancer or Tumor Profiling Production Volume Share by Type (2018-2023)

    • Figure South China Cancer or Tumor Profiling Production Volume Share by Type (2018-2023)

    • Table South China Cancer or Tumor Profiling Sales Volume by Application (2018-2023)

    • Table South China Cancer or Tumor Profiling Sales Volume Share by Application (2018-2023)

    • Figure South China Cancer or Tumor Profiling Sales Volume Share by Application (2018-2023)

    • Table East China Cancer or Tumor Profiling Production Volume by Type (2018-2023)

    • Table East China Cancer or Tumor Profiling Production Volume Share by Type (2018-2023)

    • Figure East China Cancer or Tumor Profiling Production Volume Share by Type (2018-2023)

    • Table East China Cancer or Tumor Profiling Sales Volume by Application (2018-2023)

    • Table East China Cancer or Tumor Profiling Sales Volume Share by Application (2018-2023)

    • Figure East China Cancer or Tumor Profiling Sales Volume Share by Application (2018-2023)

    • Table Northeast China Cancer or Tumor Profiling Production Volume by Type (2018-2023)

    • Table Northeast China Cancer or Tumor Profiling Production Volume Share by Type (2018-2023)

    • Figure Northeast China Cancer or Tumor Profiling Production Volume Share by Type (2018-2023)

    • Table Northeast China Cancer or Tumor Profiling Sales Volume by Application (2018-2023)

    • Table Northeast China Cancer or Tumor Profiling Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Cancer or Tumor Profiling Sales Volume Share by Application (2018-2023)

    • Table Southwest China Cancer or Tumor Profiling Production Volume by Type (2018-2023)

    • Table Southwest China Cancer or Tumor Profiling Production Volume Share by Type (2018-2023)

    • Figure Southwest China Cancer or Tumor Profiling Production Volume Share by Type (2018-2023)

    • Table Southwest China Cancer or Tumor Profiling Sales Volume by Application (2018-2023)

    • Table Southwest China Cancer or Tumor Profiling Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Cancer or Tumor Profiling Sales Volume Share by Application (2018-2023)

    • Table Northwest China Cancer or Tumor Profiling Production Volume by Type (2018-2023)

    • Table Northwest China Cancer or Tumor Profiling Production Volume Share by Type (2018-2023)

    • Figure Northwest China Cancer or Tumor Profiling Production Volume Share by Type (2018-2023)

    • Table Northwest China Cancer or Tumor Profiling Sales Volume by Application (2018-2023)

    • Table Northwest China Cancer or Tumor Profiling Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Cancer or Tumor Profiling Sales Volume Share by Application (2018-2023)

    • Table Oxford Gene Technology Company Profile

    • Table Oxford Gene Technology Cancer or Tumor Profiling Revenue, Price and Gross (2018-2023)

    • Table Caris Life Sciences Helomics Corporation Company Profile

    • Table Caris Life Sciences Helomics Corporation Cancer or Tumor Profiling Revenue, Price and Gross (2018-2023)

    • Table Personal Genome Diagnostics Company Profile

    • Table Personal Genome Diagnostics Cancer or Tumor Profiling Revenue, Price and Gross (2018-2023)

    • Table Ribomed Biotechnologies, Inc Company Profile

    • Table Ribomed Biotechnologies, Inc Cancer or Tumor Profiling Revenue, Price and Gross (2018-2023)

    • Table Genomic Health Inc Company Profile

    • Table Genomic Health Inc Cancer or Tumor Profiling Revenue, Price and Gross (2018-2023)

    • Table Foundation Medicine Company Profile

    • Table Foundation Medicine Cancer or Tumor Profiling Revenue, Price and Gross (2018-2023)

    • Table Qiagen NV Company Profile

    • Table Qiagen NV Cancer or Tumor Profiling Revenue, Price and Gross (2018-2023)

    • Table Nanostring Technologies Company Profile

    • Table Nanostring Technologies Cancer or Tumor Profiling Revenue, Price and Gross (2018-2023)

    • Table GenomeDX Company Profile

    • Table GenomeDX Cancer or Tumor Profiling Revenue, Price and Gross (2018-2023)

    • Table HTG Molecular Diagnostics Company Profile

    • Table HTG Molecular Diagnostics Cancer or Tumor Profiling Revenue, Price and Gross (2018-2023)

    • Table Guardant Health Company Profile

    • Table Guardant Health Cancer or Tumor Profiling Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US